|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction-, an international, multicenter, randomized, placebo-controlled trial显示文摘 | Udelson JE Orlandi C Ouyang J | 2008 | J AmColl Cardiol2008，52，19： | 1 |
| 2 | 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST- elevation cardial infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines 显示文摘 | Antman EM Hand M Armstrong PW | 2008 | Amcoll Cardiol2008，51，： | 1 |
| 3 | Incremental value ofcopeptin for rapid rule out of acute myocardial infarction显示文摘 | Reichlin T Hochholzer W Stelzig C | 2009 | J AmColl Cardiol2009，54，1： | 1 |
| 4 | Diabetes mellitus and the clinical and angiographic outcome after coronary stent piacement显示文摘 | Elezi S Kastrati A Paehe J | 1998 | J AmColl Cardiol1998，32，7： | 1 |
| 5 | Changes in collateralchannel filling immediately after controlled coronary arteryocclusion by an angioplasty balloon in human subjects显示文摘 | Rentrop KP Cohen M Blanke H | 1985 | J AmColl Cardiol1985，5，： | 1 |
| 6 | Effects of dual-chamber pacing forpediatric patients with hypertrophic obstructive cardiomyopathy显示文摘 | Rishi F Hulse JE Auld DO | 1997 | J AmColl Cardiol1997，29，4： | 1 |
| 7 | Visualization of coronary atherosclerotic plaques in patients using optical coherence tomo- graphy:comparison with intravascular ultrasound显示文摘 | JangIK Bouma BE Kang DH | 2002 | J AmColl Cardiol2002，39，： | 1 |
| 8 | Digital assessment ofendothelial function and ischemic heart disease in women显示文摘 | Matsuzawa Y Sugiyama S Sugamura K | 2010 | J AmColl Cardiol2010，55，16： | 1 |
| 9 | Roles of rho-associated kinaseand oxidative stress in the pathogenesis of aortic stiffness 显示文摘 | Noma K Goto CtNishioka K | 2007 | J AmColl Cardiol2007，49，6： | 1 |
| 10 | Growth differentiation factor5 regulates cardiac repair after myocardial infarction显示文摘 | Zaidi SH Huang Q Momen A | 2010 | J AmColl Cardiol2010，2，： | 1 |
| 11 | Aspirin,betablocker,and an-giotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction显示文摘 | Berger AK Duval S Krumholz HM | 2003 | J AmColl Cardiol2003，42，2： | 1 |
| 12 | Pentraxin 3 is a newinflammatory marker correlated with left ventricular diastolicdysfunction and heart failure with normal ejection fraction显示文摘 | Matsubara J Sugiyama S Nozaki T | 2011 | J AmColl Cardiol2011，57，7： | 1 |
| 13 | Muhidisciplinary strategies for theman agement of heart failure patients athigh risk for admission: a systema ticreview of randomized trials 显示文摘 | McAlister F A Stewart S Ferrua S | 2004 | J AmColl Cardiol2004，44，4： | 1 |
| 14 | Heart rate turbulence: standards of measurement,physiological interpretation, and clinical use: Intemational Society for Hoher and Noninvasive Electrophysiology Consensus显示文摘 | Baure A Malik M Schmidt G | 2008 | AmCol Cardiol2008，52，17： | 1 |
| 15 | Antecedent hy-pertension and heart failure after myocardial infarction显示文摘 | Richards AM Nicholls MG Troughton RW | 2002 | J AmColl Cardiol2002，39，7： | 1 |
| 16 | Impact of major bleedingon 30-day mortality and clinical outcomes in patients with acutecoronary syndromes:an analysis from the ACUITY Trial显示文摘 | Manoukian SV Feit F Mehran R | 2007 | J AmColl Cardiol2007，49，12： | 1 |
| 17 | Hydroxyl radicalgeneration,levels of tumor necrosis factor-alpha,and progres-sion to heart failure after acute myocardial infarction显示文摘 | Valgimigli M Merli E Malagutti P | 2004 | J AmColl Cardiol2004，43，11： | 1 |
| 18 | Plasma brain na-triuretic peptide concentration:impact of age and gender显示文摘 | Redfield MM Rodeheffer RJ Jacobsen SJ | 2002 | J AmColl Cardiol2002，40，5： | 1 |
| 19 | Anticoagulant and antiplatelet therapy use in 426patients with atrial fibrillation undergoing percutane-ous coronary intervention and stent implantation im-plications for bleeding risk and prognosis 显示文摘 | RUIZ-NODAR J M MARIN F HURTADO J A etal | 2008 | J AmColl Cardiol2008，51，81： | 1 |
| 20 | Randomized comparison of upstreamtirofiban versus downstream high bolus dose tirofiban or abciximab on tissuelevel perfusion and troponin release in high-risk acute coronary syndromes trea-ted with percutaneous coronary interventions:the EVEREST trial显示文摘 | Bolognese L Falsini G Liistro F | 2006 | J AmColl Cardiol2006，47，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员